DocuSign (DOCU) Stock Falls 4% After Morgan Stanley Downgrade to Underweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/16/2024
- Wall Street stocks end mixed on higher Treasury yields, rate expectations
- Powell says recent inflation data point to need to keep rates higher for longer
- UnitedHealth (UNH) beats earnings, revenue estimates in Q1; shares up
- Bank of America profit hurt by losses on credit cards, office loans
- Morgan Stanley (MS) earnings beat lifts stock
- Trump Media & Technology Group (DJT) Files S-1
- Tesla (TSLA) Senior VP Drew Baglino Is Said To Leave The Company - Bloomberg
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- General Motors (GM) Said to be Moving Detroit HQ to Dan Gilbert's Hudson Tower - Bloomberg
- Biohaven Pharma (BHVN) presents update on degrader platform and summary of progress to date in Phase 1 single ascending dose study for BHV-1300
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
- Midday movers: Goldman Sachs and Meta Platforms rise; Apple and Tesla fall
- Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall
DocuSign Inc. (DOCU) Restructuring Timing 'Interesting' According to Analyst
September 29, 2022 12:52 PM EDTWolfe Research cut its price target on shares of DocuSign Inc. (NASDAQ: DOCU) to $44 from $53, reiterating an Underperform rating on Thursday, in reaction to the news that the company authorized a restructuring plan that will reduce the current workforce by approximately 9%.
Analyst Alex Zukin told investors in a research article that the company estimates it will incur charges of approximately $30-$40M in connection with... More
Docusign Inc. (DOCU) PT Lowered to $55 at RBC Capital
September 29, 2022 6:10 AM EDTRBC Capital analyst Rishi Jaluria lowered the price target on Docusign Inc. (NASDAQ: DOCU) to $55.00 (from $65.00) while maintaining a Sector Perform rating.... More
'We find the timing a bit interesting' - Needham on DocuSign's (DOCU) Plans
September 29, 2022 5:45 AM EDTNeedham & Company analyst Scott Berg on DocuSign (NASDAQ: DOCU): "We find the timing a bit interesting given newly announced CEO Allan Thygesen has yet to start, but we assume he was fully consulted and signed off on the plan since he will be critical in... More
Wolfe Research Upgrades Docusign Inc. (DOCU) to Underperform
September 29, 2022 3:15 AM EDTWolfe Research analyst Alex Zukin upgraded Docusign Inc. (NASDAQ: DOCU) from to Underperform with a price target of $44.00 (from $53.00).
For an analyst ratings summary and ratings history on Docusign Inc. click here. For more ratings news on Docusign Inc. click here.
Shares of Docusign Inc. closed at $55.31 yesterday.
... More
